Strides Pharma Nine Monthly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
Gross Sales	2702.02	2204.23	2407.38	2133.33	1562.19
Excise Duty	--	--	--	--	--
Net Sales	2702.02	2204.23	2407.38	2133.33	1562.19
Other Operating Income	--	--	--	--	--
Other Income	81.78	45.93	97.44	127.88	285.37
Total Income	2783.79	2250.16	2504.81	2261.21	1847.56
Total Expenditure	2681.77	2500.56	2007.78	1758.51	1438.02
PBIDT	102.03	(250.39)	497.03	502.70	409.54
Interest	180.63	127.26	108.46	115.39	55.93
PBDT	(78.60)	(377.65)	388.58	387.31	353.61
Depreciation	182.32	172.34	154.43	128.36	87.74
Minority Interest Before NP	--	--	--	--	--
Tax	(16.03)	4.08	21.33	39.69	13.01
Deferred Tax	(46.36)	(50.86)	(1.17)	(17.89)	(32.31)
Reported Profit After Tax	(198.54)	(503.21)	213.99	237.16	285.17
Minority Interest After NP	(5.44)	(13.78)	(8.37)	(3.16)	8.07
Net Profit after Minority Interest	(193.09)	(489.43)	222.36	240.32	277.10
Extra-ordinary Items	8.88	(165.64)	39.98	78.96	(20.25)
Adjusted Profit After Extra-ordinary item	(201.97)	(323.79)	182.38	161.36	297.35
EPS (Unit Curr.)	(21.45)	(54.54)	24.82	26.83	30.94
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	90.29	89.78	89.63	89.55	89.55
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	3.78	(11.36)	20.65	23.56	26.22
PBDTM(%)	(2.91)	(17.13)	16.14	18.16	22.64
PATM(%)	(7.35)	(22.83)	8.89	11.12	18.25